ArticleJournal of managed care & specialty pharmacy2024

Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release.

Jeff Schein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.